ADC Therapeutics
Developing targeted cancer therapy
- B2B
About ADC Therapeutics
Commercial-stage biotech company developing next-generation targeted antibody drug conjugates to improve outcomes for cancer patients with hematological and solid tumors
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Lausanne, Vaud, Switzerland
- Founded
- 2011
- Revenue
- $81.4MFY2025, publicly reported
- Website
- adctherapeutics.com
ADC Therapeutics at a glance
ADC Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Lausanne, Vaud, Switzerland.
ADC Therapeutics was founded in 2011.
ADC Therapeutics has 251–1,000 employees.
ADC Therapeutics's revenue is $81.4M (FY2025, publicly reported).
Frequently asked questions about ADC Therapeutics
What is ADC Therapeutics's revenue?
ADC Therapeutics's revenue is $81.4M (FY2025, publicly reported).
How many employees does ADC Therapeutics have?
ADC Therapeutics has 251–1,000 employees.
Where is ADC Therapeutics headquartered?
ADC Therapeutics is headquartered in Lausanne, Vaud, Switzerland.
Selling to companies like ADC Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies